FDA approves Roche breast cancer drug, potential blockbuster launch
Published 1 d ago1 sourceEvidence: Reported
The European Commission approved Daraxonrasib, a novel pancreatic cancer treatment, under an accelerated procedure reflecting the absence of superior alternatives. The approval expands therapeutic options for a disease with historically poor prognosis, though efficacy and long-term outcomes remain to be fully established in post-marketing settings.
AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works
Entities
Published 1 d ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 1 d ago3 sourcesEvidence: Reported
Published 1 d ago3 sourcesEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported
Published 1 d ago1 sourceEvidence: Reported
Published 2 d ago1 sourceEvidence: Reported